Excipient interference on development of a cGMP assay for PDE5
International Journal of Pharmaceutical Excipients · 31.03.2025 · 2 (1)
DOI: 10.66617/001c.133815 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Excipients, online erschienen am 31.03.2025. Verfasst von Aditya Dev und 5 weiteren Autor:innen.
Abstract (Originalsprache)
The aims of this study were to develop a simple, cost-effective assay for determination of PDE5 activity in vitro for testing of active compounds and excipients used in FDA approved products for treatment of erectile dysfunction. Several excipients used in formulations of these drugs interfered with the PDE5 assay indicating that certain excipients can exhibit pharmacological effects in vitro and are therefore not the inert materials they were described as in years past.
Zitieren
APA
Dev, A., Shintre, S., Jadhav, D., Kolhe, S., Mahindrakar, K., & Padmanabhan, S. (2025). Excipient interference on development of a cGMP assay for PDE5. International Journal of Pharmaceutical Excipients, 2(1). https://doi.org/10.66617/001c.133815
Vancouver
Dev A, Shintre S, Jadhav D, Kolhe S, Mahindrakar K, Padmanabhan S. Excipient interference on development of a cGMP assay for PDE5. International Journal of Pharmaceutical Excipients. 2025;2(1). doi:10.66617/001c.133815
BibTeX
@article{Dev2025,
author = {Dev, Aditya and Shintre, Somesh and Jadhav, Damini and Kolhe, Sanman and Mahindrakar, Komal and Padmanabhan, Sriram},
title = {Excipient interference on development of a cGMP assay for PDE5},
journal = {International Journal of Pharmaceutical Excipients},
year = {2025},
volume = {2},
number = {1},
doi = {10.66617/001c.133815}
}
EUVIMED